{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T22:24:59Z","timestamp":1758925499544},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/gme.0b013e31829ef343","type":"journal-article","created":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T19:49:38Z","timestamp":1375818578000},"page":"195-197","source":"Crossref","is-referenced-by-count":8,"title":["Use of drug holidays in women taking bisphosphonates"],"prefix":"10.1097","volume":"21","author":[{"given":"Dima L.","family":"Diab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson B.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210211","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"R2-17-20210211","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years experience with alendronate for osteoporosis in postmenopausal women.","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-17-20210211","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMc062792","article-title":"Prolonged bisphosphonate release after treatment in children.","volume":"356","author":"Papapoulos","year":"2007","journal-title":"N Engl J Med"},{"key":"R4-17-20210211","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1185\/030079904125004475","article-title":"Bone safety of long-term bisphosphonate treatment.","volume":"20","author":"Rodan","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"R6-17-20210211","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jbmr.1494","article-title":"The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT).","volume":"27","author":"Black","year":"2012","journal-title":"J Bone Miner Res"},{"key":"R7-17-20210211","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00223-004-0286-7","article-title":"Seven years of treatment with risedronate in women with postmenopausal osteoporosis.","volume":"75","author":"Mellstrom","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"R8-17-20210211","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"R9-17-20210211","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbmr.11","article-title":"Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial.","volume":"25","author":"Schwartz","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R10-17-20210211","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00198-007-0460-7","article-title":"Fracture risk remains reduced one year after discontinuation of risedronate.","volume":"19","author":"Watts","year":"2008","journal-title":"Osteoporos Int"},{"key":"R11-17-20210211","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1210\/jc.2011-0412","article-title":"Effect of stopping risedronate after long-term treatment on bone turnover.","volume":"96","author":"Eastell","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-17-20210211","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14219\/jada.archive.2010.0082","article-title":"The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program.","volume":"141","author":"Grbic","year":"2010","journal-title":"J Am Dent Assoc"},{"key":"R13-17-20210211","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","article-title":"Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.","volume":"362","author":"Black","year":"2010","journal-title":"N Engl J Med"},{"key":"R16-17-20210211","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ecl.2012.04.007","article-title":"Bisphosphonates in the treatment of osteoporosis.","volume":"41","author":"Diab","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R17-17-20210211","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis.","volume":"95","author":"Watts","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-17-20210211","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jbmr.1542","article-title":"Bisphosphonate therapy for osteoporosis: the long and short of it.","volume":"27","author":"Compston","year":"2012","journal-title":"J Bone Miner Res"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GME.0b013e31829ef343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:42:59Z","timestamp":1620952979000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201402000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31829ef343","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}